(585) Impact of the SarsCov2 Booster Dose on Clinical Events in Heart Transplant Patients in Galicia. INMU TC Study

PURPOSE: Heart transplant (HT) patients have a higher risk of severity after SARS-CoV-2 (COVID-19) infection than general population. Serological response to the initial vaccination regimen is lower. The clinical impact of the booster vaccination regimen in HT patients is unknown. The INMU_TC study...

Descripción completa

Detalles Bibliográficos
Autores principales: Enriquez, D., Caballero, E. Barge, Canosa, P. Blanco, Cancela, Z. Grille, Arévalo, G. Bou, Vázquez, P. Rodríguez, Rodríguez, C. Riveiro, Mallon, D. Couto, Caballero, G. Barge, Paniagua, M., Muñiz, J., Manuel, V. José, Crespo-Leiro, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068101/
http://dx.doi.org/10.1016/j.healun.2023.02.600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068101/
http://dx.doi.org/10.1016/j.healun.2023.02.600

Ejemplares similares